Clinical Trials Insight: 700037566

Trial Profile

Clinical Trials Insight: 700037566

Phase of Trial: Phase II

Latest Information Update: 09 Oct 2009

At a glance

  • Drugs Encaleret (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Japan Tobacco; Merck & Co
  • Most Recent Events

    • 09 Oct 2009 Status changed from not stated to completed.
    • 11 Sep 2009 Results have been presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
    • 30 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top